These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 2025787

  • 21. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG, Rössner S, Walldius G, Carlson LA.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
    [Abstract] [Full Text] [Related]

  • 22. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia.
    Tilly-Kiesi M, Tikkanen MJ.
    J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of HMG-CoA reductase in mononuclear cells during gemfibrozil treatment.
    Stange EF, Osenbrügge M, Rustan M, Reimann F, Schneider A, Ditschuneit HH, Ditschuneit H.
    Atherosclerosis; 1991 Dec; 91(3):257-65. PubMed ID: 1789808
    [Abstract] [Full Text] [Related]

  • 24. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].
    Idzior-Waluś B.
    Przegl Lek; 1992 Dec; 49(10):327-33. PubMed ID: 1308286
    [Abstract] [Full Text] [Related]

  • 25. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR, Klemens UH, Vollmar LJ, Lang PD.
    Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760
    [Abstract] [Full Text] [Related]

  • 26. Activity profile of gemfibrozil on the major plasma lipoprotein parameters.
    Sirtori CR, Franceschini G, Gianfranceschi G, Vaccarino V, Chiesa G, Maderna P, Bertoli M, Calabresi L.
    Eur J Epidemiol; 1992 May 08; 8 Suppl 1():120-4. PubMed ID: 1505648
    [Abstract] [Full Text] [Related]

  • 27. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS, Vitaliano E, Rossi FG, Serra T, Santini G, Bernardi G.
    Clin Ter; 1991 Jan 15; 136(1):31-8. PubMed ID: 1826871
    [Abstract] [Full Text] [Related]

  • 28. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M, Le Goff W, Frisdal E, Schneider S, Milosavljevic D, Bruckert E, Chapman MJ.
    J Clin Endocrinol Metab; 2003 Aug 15; 88(8):3738-46. PubMed ID: 12915663
    [Abstract] [Full Text] [Related]

  • 29. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.
    Bredie SJ, Westerveld HT, Knipscheer HC, de Bruin TW, Kastelein JJ, Stalenhoef AF.
    Neth J Med; 1996 Aug 15; 49(2):59-67. PubMed ID: 8824106
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of the efficiency of gemfibrozil in treating hyperlipidemia type IIb and IV].
    Polakowska M, Broda G, Rywik S, Piotrowski W, Bednarska M, Kuźmińska A, Pytlak A, Chotkowska E.
    Pol Arch Med Wewn; 1994 Jan 15; 91(1):9-18. PubMed ID: 8190659
    [Abstract] [Full Text] [Related]

  • 31. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
    Gavish D, Oschry Y, Fainaru M, Eisenberg S.
    Eur J Clin Invest; 1986 Feb 15; 16(1):61-8. PubMed ID: 3084275
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Lovastatin in the treatment of primary hypercholesterolemia].
    Broda G, Rywik S, Chotkowska E, Bednarek M, Kuzmińska A, Polakowska M.
    Kardiol Pol; 1991 Feb 15; 35(8):84-9. PubMed ID: 1942761
    [Abstract] [Full Text] [Related]

  • 34. Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia.
    Murase T, Okubo M, Takeuchi I.
    J Clin Lipidol; 2010 Feb 15; 4(2):99-104. PubMed ID: 21122636
    [Abstract] [Full Text] [Related]

  • 35. [Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia].
    Julius U, Hora C, Gross P, Fücker K, Bergmann S, Hanefeld M.
    Fortschr Med; 1992 Dec 20; 110(35-36):669-72. PubMed ID: 1487226
    [Abstract] [Full Text] [Related]

  • 36. Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects.
    Jones PH, Pownall HJ, Patsch W, Herd JA, Farmer JA, Payton-Ross C, Kimball KT, Gotto AM, Morrisett JD.
    J Lipid Res; 1996 Jun 20; 37(6):1298-308. PubMed ID: 8808764
    [Abstract] [Full Text] [Related]

  • 37. [Gemfibrozil in the treatment of hyperlipoproteinemias].
    Monova D, Petrova V, Belovezhdov N.
    Vutr Boles; 1991 Jun 20; 30(2):56-8. PubMed ID: 1891900
    [Abstract] [Full Text] [Related]

  • 38. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
    Hasler-Rapacz J, Kempen HJ, Princen HM, Kudchodkar BJ, Lacko A, Rapacz J.
    Arterioscler Thromb Vasc Biol; 1996 Jan 20; 16(1):137-43. PubMed ID: 8548414
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.
    Civeira F, Cenarro A, Ferrando J, Puzo J, Garcia-Otín AL, Mozas P, Pocoví M.
    Am Heart J; 1999 Jul 20; 138(1 Pt 1):156-62. PubMed ID: 10385780
    [Abstract] [Full Text] [Related]

  • 40. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil.
    Zhao SP, Smelt AH, Leuven JA, Vroom TF, van der Laarse A, van 't Hooft FM.
    Am J Med; 1994 Jan 20; 96(1):49-56. PubMed ID: 8304363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.